Furthermore, next-generation sequencing (NGS) investigations have revealed the presence of supplementary driver genes in primary tumors of SCLC, with the universal biallelic inactivation of Rb and TP53 genes [31,32,33]. The gene discussed is TP53; the disease is small cell lung carcinoma.